NCT00044590

Brief Summary

Parkinson's disease (PD) occurrence is higher in rural than in urban populations of industrialized countries. Epidemiologic and human tissue studies suggest that pesticides may be responsible for causing dopaminergic cell death at increased rates. While many pathophysiologic pathways may be involved in the neurodegeneration responsible for PD, genetic factors are likely to determine a general susceptibility to neurodegeneration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,870

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2000

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

September 3, 2002

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 5, 2002

Completed
14.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2016

Completed
Last Updated

May 16, 2017

Status Verified

May 1, 2017

Enrollment Period

16.3 years

First QC Date

September 3, 2002

Last Update Submit

May 12, 2017

Conditions

Keywords

Parkinson's diseasePesticidesGenetic susceptibilityPolymorphisms

Study Arms (2)

Cases

Patients with Parkinson's Disease

Controls

Controls, subjects without Parkinson's Disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Our case population consists of patients with newly diagnosed idiopathic Parkinson's disease living in central California; they will be patients who have elicited care from health care providers. Controls will be randomly selected from Medicare records and matched to cases according to age, race, and sex.

You may qualify if:

  • first Parkinson's disease (PD) diagnosis after January 1998
  • currently living in one of the three target counties (Kern, Tulare, Fresno)
  • have lived in California for at least 5 years

You may not qualify if:

  • have not been diagnosed with idiopathic PD
  • first PD diagnosis before January 1998
  • currently living outside of Kern, Tulare, or Fresno counties
  • have lived in California for fewer than 5 years
  • have never been diagnosed with PD
  • currently living in one of the three target counties (Kern, Tulare, Fresno)
  • have lived in California for at least 5 years
  • have been diagnosed with PD
  • currently living outside of Kern, Tulare, or Fresno counties
  • have lived in California for fewer than 5 years
  • For each patient, one or more unaffected sibling controls and one population control will be recruited. The population control are being selected randomly from Medicare records (95% of all controls) and residential parcel listings (for those patients younger than 65 years of age only). The controls are being marginally matched to cases according to 5-year age categories (e.g. 50-54, 55-59, 60-64, etc.), race (white, African-American, Asian, Hispanic, other), and sex. All study cases by definition will be patients who elicited care from health care providers. We are aiming to enroll every newly diagnosed PD patient into our study and expect patient population participating in our study that is as diverse as the rural population.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beate Ritz, UCLA Department of Epidemiology

Los Angeles, California, 90095-1772, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, saliva, urine, and stool samples

MeSH Terms

Conditions

Parkinson DiseaseGenetic Predisposition to Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDisease SusceptibilityDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Beate Ritz, MD, PhD

    UCLA Department of Epidemiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
NIH
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 3, 2002

First Posted

September 5, 2002

Study Start

September 1, 2000

Primary Completion

November 30, 2016

Study Completion

November 30, 2016

Last Updated

May 16, 2017

Record last verified: 2017-05

Locations